Saturday 7 November 2026 Export RGNX’s income statement to Excel — free account

REGENXBIO Inc.

RGNX Healthcare Biotechnology

REGENXBIO Inc.’s revenue for fiscal 2025 (year ended December 2025) was $170.4 million, up 104.5% from fiscal 2024.

Revenue: −69.2%
EPS: +48.0%
Free cash flow: +168.1%

Quarter to September 2026, against a year earlier

Insider buying

7.56 0.18 +2.44%

Follow RGNX

Alert me

Market cap: $487.2M
P/E: 0.0×
Fwd P/E: −2.2×
Dividend yield: —
F-score: 5/9
Altman Z: −2.57
Beneish M: −2.77
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	2	3	5
ROE Full definition →		(107.00%)	(196.43%)	(137.63%)	(113.24%)
ROA Full definition →		(42.19%)	(69.65%)	(40.60%)	(35.36%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(72.33%)	(133.47%)	(77.95%)	(50.27%)
Average Days of Receivables Full definition →		56.49	41.72	223.32	20.24
Free Cash Flow per Share Full definition →		(2.45)	(4.51)	(4.73)	(2.37)
Free Cash Flow Full definition →		(126.38)	(236.40)	(249.67)	(154.80)
Capital Expenditures Full definition →		(2.41)	(2.62)	(2.99)	(2.70)
Other line items
Cash ROIC Full definition →		(37.97%)	(137.79%)	(140.65%)	(38.77%)
Accounts Receivable Turnover Full definition →		7.28	6.22	2.75	9.08
Accounts Payable Turnover Full definition →		0.92	1.39	1.28	1.07
Inventory Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		384.06	277.08	238.73	256.50
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		133.95%	264.80%	131.32%	152.07%
Selling, General and Administrative Expense of Revenue Full definition →		48.62%	95.45%	49.03%	55.80%
Share Based Compensation of Revenue Full definition →		20.28%	39.45%	20.08%	22.20%
Interest Coverage Full definition →		(3.58)	(5.69)	(3.91)	(4.06)
Operating CF/Net income Full definition →		0.64	0.81	1.26	0.87
Depreciation/Fixed assets Full definition →		0.15	0.15	0.17	0.00
Capex/Depreciation Full definition →		(0.15)	(0.17)	(0.18)	0.00
Revenue per Share Full definition →		3.30	1.68	3.30	2.36
Operating CF per Share Full definition →		(2.40)	(4.46)	(4.67)	(2.33)
Capex per Share Full definition →		(0.05)	(0.05)	(0.06)	(0.04)
Capex to Sales Full definition →		0.01	0.03	0.02	0.02

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly